FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to carrying out pre-clinical tests of medications with application of transcutaneous electric pain stimulation. Device for transcutaneous electric pain stimulation of laboratory animals includes illuminated compartment, connected with darkened compartment, which has electrode floor, via a door. Illuminated compartment is provided with detachable source of light with graduated regulator of illumination and has transparent walls with non-transparent covering in the lower part. Electrode floor is made in form of two separate metal plates, electrically isolated from each other, has possibility to move outwards and is connected to electrical stimulator and microammeter.
EFFECT: application of the invention will make it possible to increase efficiency of installation operation due to ensuring required threshold or above-threshold transcutaneous electric pain stimulation with application of low-power electrical stimulators and selection of individual parameters of stimulation in work with different animals.
4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ELECTRODE PLATFORM FOR ELECTROALGESIC STIMULATION OF ANIMALS | 2017 |
|
RU2675174C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| WATER-SOLUBLE SALAMIDE DERIVATIVE POSSESSING TRANQUILISING, NOOTROPIC AND ANALGESIC ACTIVITY | 2012 |
|
RU2540464C2 |
| APPLICATION OF 1-HETARYL-2-NITRO-2-(3-PHENYL-1,2,4-OXADIAZOLE-5-YL)ETHANES AS PSYCHOTROPIC SUBSTANCES | 2009 |
|
RU2420521C1 |
| DEVICE FOR TESTING LABORATORY ANIMALS | 0 |
|
SU1709998A1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIHYPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY | 2012 |
|
RU2480233C1 |
